Hypertensive nephropathy: a major roadblock hindering the advance of precision nephrology

In the 2017 Annual Report of the ERA-EDTA Registry, hypertension continues to be the second or third most common cause of renal replacement therapy (RRT) in Europe, tied with glomerulonephritis. There is, however, one little issue: hypertension-induced end-stage renal disease (ESRD) might not exist...

Descripción completa

Detalles Bibliográficos
Autores principales: Carriazo, Sol, Vanessa Perez-Gomez, Maria, Ortiz, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Editorial Comments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467619/
https://www.ncbi.nlm.nih.gov/pubmed/32897275
http://dx.doi.org/10.1093/ckj/sfaa162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467619/
https://www.ncbi.nlm.nih.gov/pubmed/32897275
http://dx.doi.org/10.1093/ckj/sfaa162

Ejemplares similares